pragma.vision Technology observatory & strategic foresight

Verification register Bio, Health & Neuro

Living definition

What is Teclistamab + daratumumab (Tecvayli combination)?

Vaccines & Immunotherapy Bio, Health & Neuro

As of
2026-08-20
Revision
2026-08-17.1
Method
v1.3.0

Definition

The term, in context

AI-assisted draft · approved dataset

This combination pairs teclistamab, sold as Tecvayli, with the antibody daratumumab, using two different immune-targeting mechanisms together against multiple myeloma.

Live readiness status

Status as of the current dateline

AI-assisted assembly · derived results

As of 2026-08-20, verified readiness is 83 (claimed 90, reported 89, gap 7) — Strong evidence strength; current signals suggest Adopt with guardrails.

The readiness fact belongs to the canonical Readiness Verdict for Teclistamab + daratumumab (Tecvayli combination).

Dataset approval

Human editorial release

pragma.vision editorial — standing authorization (operator dev@soft.house, 2026-07-17)

Dataset
2026-08-17.1
Hash
sha256:0c37108a182f510fc8cf4d1dfc3a30339f2b59e62654201edea2f530a268707e
Approved
2026-08-17

Your opinion

Tell us anything.

What works, what doesn't, what's missing — especially about our watches, lenses, and the register itself. Anonymous is fine; leave an email if you'd like a reply.